# NECTORS (NCT04277858)

> Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04277858
- Phase: PHASE2
- Status: UNKNOWN
- Sponsor: Nader Sadeghi
- Conditions: Oropharynx Cancer; Tonsil Cancer; Throat Cancer; Base of the Tongue Carcinoma
- Interventions: Docetaxel
- Enrollment: 60
- Primary outcome: Primary outcome: progression free survival.

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 2
- Bluesky threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nectors-nct04277858